Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / ORDINARY SHARES
-
Total 13F shares
-
9,327,561
-
Share change
-
-2,141,016
-
Total reported value
-
$4,887,438
-
Price per share
-
$0.54
-
Number of holders
-
10
-
Value change
-
-$1,215,369
-
Number of buys
-
1
-
Number of sells
-
6
Institutional Holders of YS BIOPHARMA CO LTD - ORDINARY SHARES (LSB) as of Q4 2023
As of 31 Dec 2023,
YS BIOPHARMA CO LTD - ORDINARY SHARES (LSB) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,327,561 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FIL Ltd, Valliance Asset Management Ltd, FMR LLC, HHLR ADVISORS, LTD., SUPERSTRING CAPITAL MANAGEMENT LP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, WOLVERINE ASSET MANAGEMENT LLC, and Tower Research Capital LLC (TRC).
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.